“…Both modalities have high local control, larynx preservation and high diseasespecific survival rates, and all retrospective data available in the literature show that these two treatment modalities are comparable for T1a glottic cancer. However, no randomized trial has been performed and the choice of the treatment is often based on the local expertise and/or patient preference [8,14,23,39,40,42,46,54].Over the last decade, functional outcome and voice quality seem to play a key role in the treatment strategies. In fact, radiotherapy is often preferred because it seems to be associated with reduced impairment of voice quality, but qualitative studies about vocal function in post-irradiated patients have been inconclusive and not uniform [12,16,17,18,20,28,31,48,50].…”